The Mauritius and Rodrigues Non-Communicable Disease (NCD) Study
NCT ID: NCT07048717
Last Updated: 2025-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
39082 participants
OBSERVATIONAL
1987-04-05
2050-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Seven population-based cross-sectional surveys using standardised protocols were conducted between 1987 and 2021). The participation rate has been over 85% in each survey.
At each survey, participants were interviewed about living conditions, lifestyle and health, and anthropometry and blood pressure were measured. Biochemistry including lipids and an oral glucose tolerance test (OGTT) were performed Electrocardiograms (ECG) were recorded in participants aged 35 years and older. Previous participants were followed up in 2007 and 92% were successfully traced.
Studies with identical methodology have been performed on the neighbouring island Rodrigues where the majority of the population are Creoles.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups
NCT00377702
Measures of Obesity and Co-Morbid Conditions in Maori
NCT00208598
Pawtucket Heart Health Program
NCT00005151
European Study of Cardiovascular Risk
NCT00882336
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
NCT03892265
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The population in Mauritius are descendants to immigrants from South Asia, Africa and China, i.e., approximately 60% of the world population are represented. Mauritius is probably the only developing country that has followed the development of non-communicable diseases (NCD) and associated risk factors over a long time-period and continues to do so.
In the mid-eighties, the Mauritian government initiated a study on the prevalence of type 2 diabetes and cardiovascular disease, in collaboration with WHO and international experts. Altogether seven population-based surveys have been performed between 1987 and 2021, and approximately 39 000 (!) examinations have been recorded. The intention is to repeat the survey every fifth year.
The ethnicities of the participants have been 71% South Asians (India/Pakistan), 24% Creoles (Africa) and 5% Chinese, which reflects well the ethnical distribution of the population. Previous participants were followed up in 2007 and 92% were successfully traced. Studies have also been performed on the neighbouring island Rodrigues where the majority of the population are Creoles. During the follow-up survey in 2010, 97% of the 9 700 participants were traced.
At each survey, information was given and an individual consent form was signed. See attached the local (in Mauritius) ethical approval and consent form from the Mauritius survey 2021.
At each survey, participants were interviewed about living conditions, lifestyle and health, and anthropometry and blood pressure were measured. Biochemistry including lipids and an oral glucose tolerance test (OGTT) were performed Altogether approximately 28 000 electrocardiograms (ECG) were recorded in participants aged 35 years and older, all of which have been coded in Kaunas, Lithuania for signs of ischemic heart disease (Minnesota criteria) and myocardial hypertrophy.
The Mauritius NCD study was initially administrated by the International Diabetes Institute in Melbourne, Australia under the leadership of Professor Paul Zimmet together with Professor Jaakko Tuomilehto (Finland) and Professor George Alberti (United Kingdom). Today, the study is administrated and financed by the Ministry of health in Mauritius under the leadership of Doctor Sudhir Kowlessur.
Professor Stefan Söderberg at the Department of Public Health and Clinical Medicine, Umeå University, Sweden was introduced to the Mauritius NCD study during his postdoc (2001-2002) in Professor Zimmet's research team at IDI in Melbourne. Söderberg has since then continued to assist in the performance of the surveys and to analyse data. Today, Umeå university and the Department of Public Health and Clinical medicine have been granted the privilege to curate and analyse data generated in the Mauritius and Rodrigues NCD study.
Each survey has been evaluated and approved by the local ethics committee in Mauritius (see attached the approval from 2021). Analysing data in Sweden has been approved by the Swedish Ethical Authority (2023-07199-01).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Randomly selected population-based subjects from the population (Mauritius)
Seven cross-sectional studies were performed between 1987 and 2021 on mainland Mauritius
No interventions assigned to this group
Randomly selected population-based subjects from the population (Rodrigues)
In parallell, six cross-sectional studies were performed between 1992 and 2022 on Rodrigues
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Randomly selected population-based samples (details see below)
* Target age from 25 to 74 years Exclusion
* Not living in the study area
* Age outside the age-range
In detail:
In 2004, a new study was performed, with similar methodology. In 2009, nine index clusters were chosen with one randomly selected from each of the nine districts in Mauritius. Then, two neighbouring clusters were chosen surrounding the index cluster to form a "super cluster." From this super cluster, one in three households was randomly selected and one adult per household was invited to participate.5 The same methodology was used in 2015 and in 2021 with new randomly chosen clusters forming "super cluster" as in 2009. In addition, a random sample from the 1998 survey was invited for a resurvey in 2015.
Participation rate has been over 85% in each survey. No sampling weights were used.
Same methodology was used in Rodrigues.
25 Years
74 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health and Wellness, Mauritius
UNKNOWN
University of Helsinki
OTHER
Monash University
OTHER
Imperial College London
OTHER
Baker Heart and Diabetes Institute
OTHER
Umeå University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stefan Soderberg
Professor, consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Zimmet, Professor
Role: PRINCIPAL_INVESTIGATOR
Monash University
George Alberti, Professor
Role: PRINCIPAL_INVESTIGATOR
Imperial College, London, UK
Jaakko Tuomilehto, Professor
Role: PRINCIPAL_INVESTIGATOR
Helsinki University, Helsinki, Finland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Port Louis, , Mauritius
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Soderberg S, Taki H, Kowlessur S, Shaw JE, Magliano DJ, Tamosiunas A, Alberti G, Zimmet P, Tuomilehto J. Trends in the prevalence of cardiovascular disease, defined as ECG abnormalities and/or self-reported events, in Mauritius between 1987 and 2021: analysis of data from seven large population-based surveys. BMJ Open. 2025 Jun 16;15(6):e087693. doi: 10.1136/bmjopen-2024-087693.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Document Type: General information about the study plus information about application for data
View DocumentRelated Links
Access external resources that provide additional context or updates about the study.
Description of the Mauritian/Rodrigues NCD survey at Umeå University, Sweden
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-07199-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.